References
Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of NSAIDS: a meta-analysis. Ann Intern Med. 1991;115:787–96.
Wolfe MM, Lichtenstein D, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888–99.
Smalley WE, Griffin MR, Fought RL, Ray WA. Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med. 1996;11:461–9.
Ko CW, Deyo RA. Cost-effectiveness of different strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease. J Gen Intern Med. 2000;15:400–410.
Fendrick AM, Chernew ME, Hirth RA, Bloom BS, Bandekar RR, Scheiman JM. Clinical and economic effects on population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med. 1999;159:142–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fendrick, A.M., Scheiman, J.M. Decision analytic modeling and NSAID gastropathy could we be more sensitive?. J GEN INTERN MED 15, 430–431 (2000). https://doi.org/10.1046/j.1525-1497.2000.0004009.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2000.0004009.x